• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合动态对比增强磁共振成像和扩散加权成像评估新辅助化疗对宫颈癌的疗效。

Combined dynamic DCE-MRI and diffusion-weighted imaging to evaluate the effect of neoadjuvant chemotherapy in cervical cancer.

作者信息

Feng Yusen, Liu Hui, Ding Yingying, Zhang Ya, Liao Chengde, Jin Yan, Ai Conghui

机构信息

Department of Radiology, Key Laboratory of Tumor Immunological Prevention and Treatment of Yunnan Province, Kunming Yan'an Hospital, Kunming, China.

Department of Radiology, Third Affiliated Hospital of Kunming Medical University, Kunming, China.

出版信息

Tumori. 2020 Apr;106(2):155-164. doi: 10.1177/0300891619886656. Epub 2019 Nov 18.

DOI:10.1177/0300891619886656
PMID:31736439
Abstract

PURPOSE

To prospectively investigate changes in quantitative parameters of dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and the apparent diffusion coefficient (ADC) of diffusion-weighted imaging (DWI) in patients with cervical cancer before and after neoadjuvant chemotherapy (NACT).

METHODS

Thirty-eight patients with cervical cancer underwent DCE-MRI and DWI 1 week before and 4 weeks after NACT. The patients were classified into 2 groups: significant reaction (sCR) group and the non-sCR group. DCE-MRI parameters and ADC values were measured and compared between the 2 groups.

RESULTS

Before NACT, the mean K value was higher, but the mean V was lower, in the sCR group compared with the non-sCR group; these differences were statistically significant (<0.05). After NACT, the mean K value and the delta (i.e., changed) value of K were significantly lower in the sCR group compared with the non-sCR group (<0.05). However, the mean ADC and the delta value of the mean ADC between the 2 groups were slightly higher in the sCR group compared with the non-sCR group (<0.05). The area under the curve of pre-mean K, DK, and pre-mean K combined with post-mean ADC values were 0.801, 0.955, and 0.878, respectively (<0.05). The optimal cutoff values for distinguishing sCR from non-sCR were pretreatment K (0.7020 min) and DK (0.0437 min).

CONCLUSIONS

Quantitative parameters (pre-mean K, DK, and pre-mean K) combined with post-mean ADC could predict treatment efficacy more precisely. However, quantitative DCE-MRI combined with DWI could not significantly improve prognostic efficacy.

摘要

目的

前瞻性研究新辅助化疗(NACT)前后宫颈癌患者动态对比增强磁共振成像(DCE-MRI)定量参数及扩散加权成像(DWI)的表观扩散系数(ADC)的变化。

方法

38例宫颈癌患者在NACT前1周及NACT后4周接受DCE-MRI和DWI检查。患者分为2组:显著反应(sCR)组和非sCR组。测量并比较两组的DCE-MRI参数和ADC值。

结果

NACT前,sCR组的平均K值较高,但平均V值较低,与非sCR组相比,这些差异具有统计学意义(<0.05)。NACT后,sCR组的平均K值和K的变化值(即ΔK)显著低于非sCR组(<0.05)。然而,sCR组的平均ADC及两组间平均ADC的变化值略高于非sCR组(<0.05)。平均K值、ΔK值及平均K值与平均ADC值联合的曲线下面积分别为0.801、0.955和0.878(<0.05)。区分sCR与非sCR的最佳临界值为治疗前K值(0.7020 min)和ΔK值(0.0437 min)。

结论

定量参数(平均K值、ΔK值和平均K值)与平均ADC值联合可更准确地预测治疗疗效。然而,定量DCE-MRI联合DWI并不能显著提高预后评估效能。

相似文献

1
Combined dynamic DCE-MRI and diffusion-weighted imaging to evaluate the effect of neoadjuvant chemotherapy in cervical cancer.联合动态对比增强磁共振成像和扩散加权成像评估新辅助化疗对宫颈癌的疗效。
Tumori. 2020 Apr;106(2):155-164. doi: 10.1177/0300891619886656. Epub 2019 Nov 18.
2
Combined dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging to predict neoadjuvant chemotherapy effect in FIGO stage IB2-IIA2 cervical cancers.联合动态对比增强磁共振成像和弥散加权成像预测 FIGO 分期 IB2-IIA2 宫颈癌新辅助化疗效果。
Radiol Med. 2020 Dec;125(12):1233-1242. doi: 10.1007/s11547-020-01214-x. Epub 2020 May 18.
3
Dynamic contrast-enhanced magnetic resonance imaging and diffusion-weighted imaging in the activity staging of terminal ileum Crohn's disease.动态对比增强磁共振成像和扩散加权成像在末端回肠克罗恩病活动分期中的应用
World J Gastroenterol. 2020 Oct 21;26(39):6057-6073. doi: 10.3748/wjg.v26.i39.6057.
4
Assessing the Early Response of Advanced Cervical Cancer to Neoadjuvant Chemotherapy Using Intravoxel Incoherent Motion Diffusion-weighted Magnetic Resonance Imaging: A Pilot Study.使用体素内不相干运动扩散加权磁共振成像评估晚期宫颈癌对新辅助化疗的早期反应:一项初步研究。
Chin Med J (Engl). 2016 Mar 20;129(6):665-71. doi: 10.4103/0366-6999.177995.
5
Dynamic contrast-enhanced and diffusion-weighted MRI of cervical carcinoma: Correlations with Ki-67 proliferation status.宫颈癌的动态对比增强和弥散加权 MRI:与 Ki-67 增殖状态的相关性。
Magn Reson Imaging. 2024 Oct;112:136-143. doi: 10.1016/j.mri.2024.07.010. Epub 2024 Jul 17.
6
Simultaneous changes of magnetic resonance diffusion-weighted imaging and pathological microstructure in locally advanced cervical cancer caused by neoadjuvant chemotherapy.新辅助化疗引起的局部晚期宫颈癌磁共振扩散加权成像与病理微观结构的同步变化
J Magn Reson Imaging. 2015 Aug;42(2):427-35. doi: 10.1002/jmri.24779. Epub 2014 Oct 20.
7
Prediction of early response to concurrent chemoradiotherapy in cervical cancer: Value of multi-parameter MRI combined with clinical prognostic factors.预测宫颈癌同步放化疗的早期反应:多参数 MRI 联合临床预后因素的价值。
Magn Reson Imaging. 2020 Oct;72:159-166. doi: 10.1016/j.mri.2020.06.014. Epub 2020 Jul 2.
8
Prediction of the response of ocular adnexal lymphoma to chemotherapy using combined pretreatment dynamic contrast-enhanced and diffusion-weighted MRI.使用联合预处理动态对比增强和扩散加权磁共振成像预测眼附属器淋巴瘤对化疗的反应
Acta Radiol. 2016 Dec;57(12):1490-1496. doi: 10.1177/0284185116631181. Epub 2016 Jul 20.
9
Diffusion and perfusion MR parameters to assess preoperative short-course radiotherapy response in locally advanced rectal cancer: a comparative explorative study among Standardized Index of Shape by DCE-MRI, intravoxel incoherent motion- and diffusion kurtosis imaging-derived parameters.扩散和灌注磁共振参数评估局部进展期直肠癌术前短程放疗反应:DCE-MRI 标准化形状指数、体素内不相干运动和扩散峰度成像衍生参数的比较探索性研究。
Abdom Radiol (NY). 2019 Nov;44(11):3683-3700. doi: 10.1007/s00261-018-1801-z.
10
Dynamic contrast-enhanced and diffusion-weighted MR imaging in early prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer.动态对比增强和弥散加权磁共振成像在局部进展期胃癌新辅助化疗病理反应早期预测中的应用。
Abdom Radiol (NY). 2022 Oct;47(10):3394-3405. doi: 10.1007/s00261-022-03623-0. Epub 2022 Aug 2.

引用本文的文献

1
DCE-Qnet: deep network quantification of dynamic contrast enhanced (DCE) MRI.DCE-Qnet:动态对比增强(DCE)MRI 的深度网络量化。
MAGMA. 2024 Dec;37(6):1077-1090. doi: 10.1007/s10334-024-01189-0. Epub 2024 Aug 8.
2
DCE-Qnet: Deep Network Quantification of Dynamic Contrast Enhanced (DCE) MRI.DCE-Qnet:动态对比增强(DCE)磁共振成像的深度网络量化
ArXiv. 2024 May 20:arXiv:2405.12360v1.
3
Improving the efficacy and safety of concurrent chemoradiotherapy by neoadjuvant chemotherapy: a randomized controlled study of locally advanced cervical cancer with a large tumor.
新辅助化疗提高大肿瘤局部晚期宫颈癌同步放化疗的疗效和安全性:一项随机对照研究。
J Gynecol Oncol. 2024 Jan;35(1):e10. doi: 10.3802/jgo.2024.35.e10. Epub 2023 Sep 26.
4
Imaging advances in efficacy assessment of gastric cancer neoadjuvant chemotherapy.胃癌新辅助化疗疗效评估的影像学进展。
Abdom Radiol (NY). 2023 Dec;48(12):3661-3676. doi: 10.1007/s00261-023-04046-1. Epub 2023 Oct 3.
5
The Utility of Contrast-Enhanced Magnetic Resonance Imaging in Uterine Cervical Cancer: A Systematic Review.对比增强磁共振成像在子宫颈癌中的应用:一项系统评价
Life (Basel). 2023 Jun 12;13(6):1368. doi: 10.3390/life13061368.
6
Neoadjuvant chemotherapy induces an elevation of tumour apparent diffusion coefficient values in patients with ovarian cancer.新辅助化疗可诱导卵巢癌患者肿瘤表观扩散系数值升高。
BMC Cancer. 2023 Apr 1;23(1):299. doi: 10.1186/s12885-023-10760-2.
7
Multi-parametric MRI for radiotherapy simulation.多参数 MRI 用于放射治疗模拟。
Med Phys. 2023 Aug;50(8):5273-5293. doi: 10.1002/mp.16256. Epub 2023 Feb 9.
8
Dynamic contrast-enhanced and diffusion-weighted MR imaging in early prediction of pathologic response to neoadjuvant chemotherapy in locally advanced gastric cancer.动态对比增强和弥散加权磁共振成像在局部进展期胃癌新辅助化疗病理反应早期预测中的应用。
Abdom Radiol (NY). 2022 Oct;47(10):3394-3405. doi: 10.1007/s00261-022-03623-0. Epub 2022 Aug 2.
9
Treatment Strategies and Prognostic Factors of 2018 FIGO Stage IIIC Cervical Cancer: A Review.2018FIGO 期 IIIC 宫颈癌的治疗策略和预后因素:综述。
Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338221086403. doi: 10.1177/15330338221086403.
10
The role of MRI in cervical cancer > 2 cm (FIGO stage IB2-IIA1) conservatively treated with neoadjuvant chemotherapy followed by conization: a pilot study.MRI 在宫颈癌新辅助化疗后行锥切术保守治疗中的作用:一项探索性研究,肿瘤直径>2cm(FIGO 分期 IB2-IIA1)。
Radiol Med. 2021 Aug;126(8):1055-1063. doi: 10.1007/s11547-021-01377-1. Epub 2021 May 31.